Cardiomyopathy with mitochondrial damage associated with nucleoside reverse-transcriptase inhibitors [7]

New England Journal of Medicine

Volumn 347, Issue 23, 2002, Pages 1895-1896

  Frerichs, Fenneke C P ^a   Dingemans, Koert P ^b   Brinkman, Kees ^a  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; INDINAVIR; LAMIVUDINE; NEVIRAPINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ADULT; ANEMIA; CARDIOMYOPATHY; CASE REPORT; DRUG EFFECT; DRUG RESPONSE; ELECTRON MICROSCOPY; HEART MITOCHONDRION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LEG PAIN; LETTER; MALE; MUSCLE WEAKNESS; PRIORITY JOURNAL;

CARDIOMYOPATHY, DILATED; HIV INFECTIONS; HUMANS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; MITOCHONDRIA; MYOCARDIUM; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0037027996     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200212053472320     Document Type: Letter

References (3)

1. Barbara G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. N Engl J Med 1998;339:1093-9.
2. Lewis W. Cardiomyopathy in AIDS: A pathophysiological perspective. Prog Cardiovasc Dis 2000;43:151-70.
3. Domanski MJ, Sloas MM, Follmann DA, et al. Effect ofzidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus. J Pediatr 1995;127:137-46.